RESEARCH FRONTIERS INC Logo

RESEARCH FRONTIERS INC

Develops and licenses patented light-control technology for smart glass applications.

REFR | US

Overview

Corporate Details

ISIN(s):
US7609111072
LEI:
Country:
United States of America
Address:
240 CROSSWAYS PARK DR, WOODBURY

Description

Research Frontiers Inc. is a technology company that develops and licenses its patented Suspended Particle Device (SPD) light-control technology. Marketed as SPD-SmartGlass, this technology enables glass and plastic surfaces to instantly and precisely switch from clear to a user-controlled level of tint. The system operates via a film containing microscopic particles that align when an electrical voltage is applied, regulating the passage of light. Key features include rapid transition speed, variable tint control, and the ability to block over 99% of UV radiation and significant heat, enhancing energy efficiency. The company licenses its technology to a global network of partners for use in products across the automotive, aviation, marine, rail, and architectural industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2005-06-23 21:26 English 9.8 KB
2005-06-17 18:07
PRIMARY DOCUMENT
English 5.4 KB
2005-06-16 18:16 English 8.3 KB
2005-05-19 12:14 English 7.6 KB
2005-05-09 18:25
RESEARCH FRONTIERS 3-31-05 QUARTERLY REPORT ON FORM 10Q
English 29.7 KB
2005-05-04 17:48
PRIMARY DOCUMENT
English 5.4 KB
2005-04-29 11:18
RESEARCH FRONTIERS PROXY STATEMENT DATED APRIL 30, 2005
English 37.8 KB
2005-04-25 19:01
FORM 8-K RE CHANGE IN ACCOUNTANTS
English 9.0 KB
2005-04-20 16:52
PRIMARY DOCUMENT
English 5.5 KB
2005-03-18 15:16
PRIMARY DOCUMENT
English 5.4 KB
2005-03-16 18:10
RESEARCH FRONTIERS 12-31-04 ANNUAL REPORT ON FORM 10K
English 300.7 KB
2005-02-18 12:45
PRIMARY DOCUMENT
English 5.4 KB
2005-02-14 10:13
RESEARCH FRONTIERS FORM 8-K DATED FEBRUARY 14, 2005
English 38.7 KB
2005-02-14 10:11
RESEARCH FRONTIERS 424B2 PROSPECTUS SUPPLEMENT DATED FEBRUARY 11, 2005
English 22.8 KB
2005-01-19 12:45
PRIMARY DOCUMENT
English 5.4 KB

Automate Your Workflow. Get a real-time feed of all RESEARCH FRONTIERS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RESEARCH FRONTIERS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RESEARCH FRONTIERS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Circio Holding ASA Logo
Clinical-stage company developing circular RNA medicines and immunotherapies.
Norway
CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
Compugen Ltd. Logo
A clinical-stage company developing cancer immunotherapies using an AI platform.
Israel
CGEN
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.